BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Pan S, Wu X. Human umbilical cord mesenchymal stem cell-derived exosomes inhibit ovarian granulosa cells inflammatory response through inhibition of NF-κB signaling in polycystic ovary syndrome. Journal of Reproductive Immunology 2022. [DOI: 10.1016/j.jri.2022.103638] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Karam M, Najjar H, El Sabban M, Hamade A, Najjar F. Regenerative Medicine for Polycystic Ovary Syndrome: Stem Cell-Based Therapies and Brown Adipose Tissue Activation. Stem Cell Rev Rep 2023. [PMID: 36633783 DOI: 10.1007/s12015-023-10505-5] [Reference Citation Analysis]
2 Prayitno GD, Lestari K, Sartika CR, Djuwantono T, Widjaya A, Muharam R, Hidayat YM, Wulandari D, Haifa R, Naura NF, Marbun KT, Zahrah A. Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review. Medicines (Basel) 2022;10. [PMID: 36662487 DOI: 10.3390/medicines10010003] [Reference Citation Analysis]
3 Rodríguez-Eguren A, Gómez-Álvarez M, Francés-Herrero E, Romeu M, Ferrero H, Seli E, Cervelló I. Human Umbilical Cord-Based Therapeutics: Stem Cells and Blood Derivatives for Female Reproductive Medicine. Int J Mol Sci 2022;23. [PMID: 36555583 DOI: 10.3390/ijms232415942] [Reference Citation Analysis]
4 Izadi M, Rezvani ME, Aliabadi A, Karimi M, Aflatoonian B. Mesenchymal stem cells-derived exosomes as a promising new approach for the treatment of infertility caused by polycystic ovary syndrome. Front Pharmacol 2022;13:1021581. [DOI: 10.3389/fphar.2022.1021581] [Reference Citation Analysis]